Tafenoquine Oral Tablet
TQ 2020_06
Phase 2 small_molecule completed
Quick answer
Tafenoquine Oral Tablet for COVID 19 Disease is a Phase 2 program (small_molecule) at 60 DEGREES PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- 60 DEGREES PHARMACEUTICALS, INC.
- Indication
- COVID 19 Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed